- Drug Pipelines
- November 2020
- 342 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- March 2023
- 100 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- March 2023
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Saudi Arabia
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Russia
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
India
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Poland
From €1426EUR$1,500USD£1,198GBP
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
United Kingdom
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 100 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- September 2022
- 40 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more